Atea Pharmaceuticals Inc (AVIR)
3.385
+0.08
(+2.27%)
USD |
NASDAQ |
Jul 01, 16:00
3.385
0.00 (0.00%)
After-Hours: 20:00
Atea Pharmaceuticals Net Income (Quarterly): -63.17M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -63.17M |
December 31, 2023 | -39.16M |
September 30, 2023 | -33.14M |
June 30, 2023 | -28.18M |
March 31, 2023 | -35.47M |
December 31, 2022 | -34.43M |
September 30, 2022 | -8.066M |
June 30, 2022 | -31.34M |
March 31, 2022 | -42.08M |
December 31, 2021 | 117.13M |
Date | Value |
---|---|
September 30, 2021 | -28.19M |
June 30, 2021 | 1.539M |
March 31, 2021 | 30.71M |
December 31, 2020 | 20.66M |
September 30, 2020 | -17.62M |
June 30, 2020 | -9.993M |
March 31, 2020 | -3.988M |
December 31, 2019 | -4.655M |
September 30, 2019 | -3.632M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-63.17M
Minimum
Mar 2024
117.13M
Maximum
Dec 2021
-11.21M
Average
-17.62M
Median
Sep 2020
Net Income (Quarterly) Benchmarks
Cytokinetics Inc | -135.64M |
Insmed Inc | -157.09M |
PetMed Express Inc | -5.016M |
Sana Biotechnology Inc | -107.48M |
Prime Medicine Inc | -45.76M |
Net Income (Quarterly) Related Metrics
Total Expenses (Quarterly) | 69.81M |
EPS Diluted (Quarterly) | -0.75 |
Enterprise Value | -262.71M |
Earnings Yield | -57.90% |
Operating Earnings Yield | 48.93% |
Normalized Earnings Yield | 40.18 |